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Orthostatic fluid shifts reduce the effective circulating volume and thus contribute
to syncope susceptibility. Recurrent syncope has a devastating impact on quality of
life and is challenging to manage effectively. To blunt orthostatic fluid shifts, static
calf compression garments are often prescribed to patients with syncope, but have
questionable efficacy. Intermittent calf compression, which mimics the skeletal muscle
pump to minimize pooling and filtration, holds promise for the management of syncope.
We aimed to evaluate the effectiveness of intermittent calf compression for increasing
orthostatic tolerance (OT; time to presyncope). We conducted a randomized single-blind
crossover study, in which participants (n = 21) underwent three graded 60◦ head-
up-tilt tests to presyncope with combined lower body negative pressure on separate
days. Low frequency intermittent calf compression (ICLF; 4 s on and 11 s off) at
0–30 and 0–60 mmHg was applied during two tests and compared to a placebo
condition where the garment was fitted, but no compression applied. We measured
continuous leg circumference changes (strain gauge plethysmography), cardiovascular
responses (finger plethysmography; Finometer Pro), end tidal gases (nasal cannula),
and cerebral blood flow velocity (CBFv, transcranial Doppler). The 0–60 mmHg ICLF
increased OT (33 ± 2.2 min) compared to both placebo (26 ± 2.4 min; p < 0.001)
and 0–30 mmHg ICLF (25 ± 2.7 min; p < 0.001). Throughout testing 0–60 mmHg
ICLF reduced orthostatic fluid shifts compared to both placebo and 0–30 mmHg ICLF
(p < 0.001), with an associated improvement in stroke volume (p < 0.001), allowing
blood pressure to be maintained at a reduced heart rate (p < 0.001). In addition, CBFv
was higher with 0–60 mmHg ICLF than 0–30 mmHg ICLF and placebo (p < 0.001).
Intermittent calf compression is a promising novel intervention for the management of
orthostatic intolerance, which may provide affected individuals renewed independence
and improved quality of life.
Keywords: syncope, compression stockings, cardiovascular, orthostasis, filtration, venous pooling, orthostatic
tolerance
INTRODUCTION
Syncope, or fainting, refers to a transient loss of consciousness and postural tone due to cerebral
hypoperfusion, characterized by a rapid onset, short duration and spontaneous recovery (Shen
et al., 2017). Commonly triggered by orthostasis, syncope is a heterogeneous condition caused by
inadequate cardiovascular autonomic compensation for the gravitational fluid shifts that occur in
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the upright position. In patients with orthostatic syncope,
impaired autonomic control of vascular resistance and/or cardiac
output culminates in global cerebral hypoperfusion (Hansson,
1979; Hainsworth, 2004).
The lifetime cumulative incidence of syncope is estimated
to be >35% in the general population, and has a bimodal
age distribution, occurring most frequently in adolescent and
elderly individuals (Ganzeboom et al., 2006). Syncope accounts
for 1–3% of emergency department visits and up to 6% of
hospital admissions (Casini-Raggi et al., 2002; McCarthy et al.,
2009). Clinical investigations for syncope are largely aimed at
the differential diagnosis, ruling out serious or life-threatening
conditions such as cardiac syncope, epilepsy, and transient
ischemic attacks, with a low diagnostic yield (Mendu et al., 2009;
Krahn et al., 2013). The fear of missing a serious underlying
condition has led to a practice of over-investigating low-risk
patients that is taxing on the healthcare system and causes
unnecessary anxiety and uncertainty for patients and families.
Up to 30% of individuals with syncope experience recurrent
and severe episodes (Providência et al., 2011), which have a
devastating impact on quality of life – associated falls result
in injury, while recurrent episodes are distressing and lead
to reduced school attendance or community participation,
unemployment, and loss of independence (Linzer et al., 1991;
Anderson et al., 2012; Sun, 2013). Furthermore, syncope is
associated with considerable morbidity; in adults, morbidity
is equivalent to patients with chronic low back pain and
severe rheumatoid arthritis, while in pediatric populations it is
equivalent to patients with asthma, structural heart disease and
end-stage renal disease (Linzer et al., 1991; Anderson et al., 2012).
Recurrent syncope is difficult to manage effectively. Patient
counseling and lifestyle advice are the primary management
recommendations; this includes patient education, advising the
patient to avoid known triggers, increase their fluid intake
(often with salt supplementation) and to perform physical
counter-pressure maneuvers [e.g., squatting, leg crossing, limb
and/or abdominal contraction (van Dijk et al., 2006)] when
symptoms of presyncope present (Shen et al., 2017). These
recommendations are certainly beneficial, but are not usually
sufficient to fully prevent symptoms in severely affected
patients, particularly those who experience frequent episodes.
Furthermore, counter-pressure maneuvers are only useful in
patients with a sufficiently long prodrome to employ them,
and can be difficult to perform in those with impaired
gait or neuromuscular disorders. They are less effective
in patients older than 60 years (Brignole et al., 2018).
Additional strategies employed in the management of recurrent
syncope include pharmacological therapy, aimed at augmenting
vascular resistance (Midodrine) or increasing plasma volume
(Fludrocortisone), as well as cardiac pacing for syncope with
profound cardioinhibition; however, the efficacy and utility
of these approaches has been queried (El-Bedawi et al.,
1994; Connolly et al., 2003; Salim and Di Sessa, 2005;
Maggi and Brignole, 2007).
Orthostatic fluid shifts are a major contributor to syncope
susceptibility, and accordingly, present a key therapeutic
target for the management of recurrent episodes. Upon
standing, there is an immediate gravitational redistribution
of the blood volume, with blood accumulating in the
veins of the legs and splanchnic circulation due to their
increased compliance and capacitance (White and Tsikouris,
2000; Stewart, 2013). Termed “venous pooling,” this fluid
redistribution decreases the effective circulating volume,
reducing venous return, blood pressure and ultimately,
cerebral blood flow (White and Tsikouris, 2000; Ricci et al.,
2015). This fluid loss is exacerbated with prolonged standing
as the increased venous volume and hydrostatic pressure
promotes capillary filtration (Brown and Hainsworth, 1999).
In the legs, the accumulated fluid loss is considerable, with
500 ml collecting in a short 10-min head-up tilt (HUT)
at 60◦ (Brown and Hainsworth, 1999). In patients with
syncope, this fluid loss is often exaggerated, and is thus an
important contributor to the pathophysiology of these disorders
(Brown and Hainsworth, 1999).
In an attempt to minimize orthostatic fluid shifts and
associated reductions in blood pressure, patients with recurrent
syncope are often prescribed static compression garments.
These garments apply targeted external counter pressures over
the legs and/or splanchnic circulation and are currently a
class IIa recommendation for orthostatic syncope (Shen et al.,
2017; Brignole et al., 2018). Larger compression garments that
envelop the entire leg and/or abdomen have proven to be
effective at mitigating orthostatic fluid shifts and improving
hemodynamic control during short bouts of orthostatic stress,
but due to reported discomfort and difficulty both getting
into and removing them, patient compliance is poor (Benkö
et al., 2001; Raju et al., 2007). Furthermore, while sitting, there
is a reversal of the pressure gradient over the thighs, which
may actually exacerbate pooling (Walker and Lamont, 2008).
Below knee calf compression stockings are more comfortable
and are thus associated with greater patient adherence (Wade
et al., 2017); however, their efficacy in reducing orthostatic
fluid shifts and improving orthostatic tolerance, or susceptibility
to syncope, has been questioned (Protheroe et al., 2011;
Hockin et al., 2019).
In a previous study, we showed that intermittent calf
compression outperforms commonly prescribed static
compression stockings at reducing venous pooling and capillary
filtration in the calf, and effectively improves cardiovascular
control, during a short (10-min) orthostatic challenge (Hockin
et al., 2019). Intermittent compression imitates the squeezing
action of the skeletal muscle pump, minimizing venous
pooling by pushing blood up past venous one-way valves and
improving orthostatic cardiovascular control by increasing
venous return and stroke volume. We further determined that
the optimal compression paradigm for preventing orthostatic
fluid shifts and ameliorating orthostatic cardiovascular control
is low frequency (4 s on – 11 s off) compression from 0 to
60 mmHg (Hockin et al., 2019). This promising alternative to
static compression garments has the potential to improve the
management of syncope, but has not yet been shown to improve
orthostatic tolerance.
In this study, we examined the efficacy of our optimal
intermittent calf compression paradigm (0–60 mmHg; 4 s
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on–11 s off) for improving orthostatic tolerance (time to
presyncope, or near-fainting) in healthy participants. In our
earlier studies, when the intermittent compression was applied
at pressures below 0–60 mmHg, there was some blunting of
orthostatic fluid shifts, but the magnitude of this effect was not
sufficient to improve hemodynamic responses over a 10-min
orthostatic challenge (Hockin et al., 2019). However, it is
possible that this modest reduction in fluid shifts could delay the
onset of presyncope with a more severe orthostatic challenge.
Accordingly, we also considered a second, lower pressure
paradigm (0–30 mmHg; 4 s on–11 s off), to examine whether
any effect of intermittent calf compression on orthostatic
tolerance was dose-dependent. In addition to our primary
outcome measure of orthostatic tolerance, we also assessed the
influence of the intermittent compression paradigms on venous
pooling and capillary filtration, and orthostatic cardiovascular
control. We hypothesized that intermittent calf compression
would: (i) reduce venous pooling and capillary filtration in
the calf: (ii) increase stroke volume and cerebral blood flow
velocity; and (iii) reduce reliance on tachycardia to support
blood pressure, leading to an increased hemodynamic reserve,
and ultimately improving orthostatic tolerance by delaying
the onset of presyncope during severe orthostatic stress, in a
dose-dependent manner.
MATERIALS AND METHODS
Participants
We recruited 21 healthy young adults (12 males; aged
24.3 ± 4.0 years; height: 175.3 ± 7.5 cm; weight: 72.0 ± 7.9 kg;
calf circumference: 37.3 ± 2.3 cm) to participate in this study.
Prior to testing, all participants completed a brief medical
history; all were free of overt cardiovascular and neurological
disease. Of the nine women we tested, five females were using
oral contraceptives (with testing conducted during the active
phase), one female had a hormonal intrauterine device, and
three were naturally cycling. In naturally cycling women, we
controlled for menstrual phase, ensuring that all three tests
were conducted during the same phase of their menstrual cycle
(one participant was tested during the follicular phase, two
during the luteal phase). One participant was taking Accutane
(Isotretinoin), two participants were using anti-histamines
for seasonal allergies, and one participant was taking the
following medications at a steady dosage: paroxetine, bupropion,
respiridone, and dextroamphetamine.
Study Design
Head-up tilt testing, combined with lower body negative pressure
(LBNP) is the gold standard for orthostatic tolerance testing, and
can be used to determine orthostatic tolerance with a repeatability
of 1.1 ± 0.6 min (Protheroe et al., 2013). In this randomized,
single-blind (experimenter blind), placebo-controlled cross-over
study, participants underwent three graded, 60◦ HUT tests
to presyncope with combined LBNP on three separate days.
Low frequency intermittent calf compression (ICLF: 4 s on
and 11 s off) at 0–30 and 0–60 mmHg was applied starting
upon initiation of tilting during two tests and compared to
a placebo condition in which the garment was fitted, but no
compression was applied. The blinded experimenter responsible
for terminating the test could not see the compression cuffs
(the LBNP box hid the compression cuffs from experimenter
view) and the air pressure source was turned on during all three
tests so that noise levels were similar during each condition.
Within subjects we controlled for time of day, scheduling each
of the three experiments for a similar time. We tested 14
participants during the early morning, and 7 participants during
the late morning. We advised participants to eat a light breakfast
on the morning of testing and asked them to refrain from
vigorous exercise, alcohol and caffeine consumption for 12-h
prior to testing.
To standardize cuff placement and evaluate whether metrics
of calf girth and muscle size influenced the effectiveness of the
ICLF interventions, we took anthropometric measurements at
the calf using a standard tape measure and skinfold calipers
(Slim GuideTM, Creative Health Products, Plymouth, MA,
United States) on the first visit before testing. The participant’s
maximum calf and gaiter circumferences were measured and
marked to size for strain gauges and to guide the placement
of the intermittent compression cuffs. The calf circumferences
of participants ranged from 33 to 41 cm (37.3 ± 2.3 cm).
Skinfold measurements were also taken at the widest level of
the calf. Muscle cross-sectional area (MCSA) (Fuller et al., 1999;
Protheroe et al., 2011) was calculated as:
MCSA =
(
calf circumference2
4pi
)
−
(
calf circumference× skinfold thickness
2
)
− 6 (1)
Experimental Protocol
The experimental protocol is shown in Figure 1. While
participants laid supine on a manual tilt table with a footboard
support, they were instrumented with cardiovascular monitoring
equipment and familiarized with the experimental protocol.
Participants were given a 20 min supine rest period to assess
supine (baseline) cardiovascular parameters and allow pooled
fluid in the legs to be reabsorbed. The orthostatic stress test
began with 20 min of 60◦ HUT, after which, LBNP was applied
and incremented (−20, −40, −60 mmHg) at 10 min intervals
while the participant was still upright. The test was terminated
at presyncope, at participant request, or upon completion
of the entire protocol. Presyncope was defined as a systolic
blood pressure less than 80 mmHg, or a heart rate (HR)
below 50 bpm or greater than 170 bpm, and/or the onset of
presyncopal symptoms such as nausea, light-headedness, tunnel-
vision, warmth and perspiration. The manual tilt table was
rapidly tilted back to the supine position when any of these
end-points were reached, orthostatic tolerance was defined as
the time in minutes from tilt start to test termination (the
time to presyncope).
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FIGURE 1 | Experimental protocol. On each test day participants provided written informed consent, were familiarized with the experimental procedures, and were
instrumented with cardiovascular and plethysmographic monitoring. After 20 min of supine rest they underwent a 60◦ head-up tilt test to presyncope with combined,
graded lower body negative pressure. After 20 min upright, lower body negative pressure was applied and incremented (–20, –40, –60 mmHg) at 10 min intervals.
The test was terminated at presyncope, at participant request or upon completion of the entire protocol. Orthostatic tolerance was determined as the time from tilt
start to test termination. On each of the three test days, a different compression paradigm was applied: 0–30 mmHg low frequency intermittent compression,
0–60 mmHg low frequency intermittent compression, or a placebo condition where the garment was fitted but no compression was applied. LBNP, lower body
negative pressure.
Cardiovascular Monitoring
We used the Finometer ProTM device (Finometer, Finapres
Medical Systems, Amsterdam, Netherlands) to monitor
cardiovascular parameters continuously and non-invasively
throughout testing. This device measures beat-to-beat
systolic (SAP), diastolic (DAP) and mean (MAP) arterial
pressure from the digital arteries in the middle finger using
photoplethysmography and reconstructs the brachial arterial
pressure waveform. This device is equipped with the Modelflow
algorithm to enable estimation of stroke volume (SV) on
a beat-to-beat basis (Wesseling et al., 1993; Jellema et al.,
1996; Harms et al., 1999). A lead II electrocardiogram (ECG;
Finapres ECG Module, Finapres Medical Systems, Amsterdam,
Netherlands) monitored HR and rhythm throughout testing
and cardiac output (CO) was calculated as the product of HR
and SV. Total peripheral resistance (TPR) was calculated as
MAP divided by CO. We also measured the partial pressures
of end tidal oxygen (PETO2) and carbon dioxide (PETCO2)
on a breath-by breath basis (O2Cap Oxygen Analyzer, Oxigraf
Inc, Sunnyvale, CA, United States) using a nasal cannula.
We determined mean cerebral blood flow velocity (CBFv)
continuously and non-invasively from the middle cerebral
artery using a 2 MHz ultrasound probe positioned over
the left temporal window and secured in position using a
headband. With the arm supported at heart level, brachial
blood flow velocity was recorded continuously and non-
invasively using an 8 MHz ultrasound probe, held in place by
an adjustable clamp (Doppler Box, Compumedics Germany
GmbH, The DWL Doppler Company, Singen, Germany).
Forearm vascular resistance (FVR) was calculated as MAP
divided by brachial blood flow velocity (Claydon et al.,
2019). All cardiovascular recordings were sampled at 1 KHz
using an analog-to-digital converter (Powerlab 16/30, AD
Instruments, Colorado Springs, CO, United States) and stored
for offline analysis.
Lower Limb Plethysmography
Estimations of limb volume changes (mL/100 mL of tissue),
expressed as percentage changes from the supine volume, were
performed using strain-gauge plethysmography. We placed two
strain gauges on each leg, the first at the level of maximum calf
circumference (the compression garment was centered over this
strain gauge), while the second was positioned at the gaiter (mid-
point between the level of maximum calf circumference and the
medial malleolus). The strain gauge positioned at the gaiter was
used to monitor the formation of edema distal to the site of
compression. Strain gauge plethysmography data were analyzed
during the compression-free (off) phase during intermittent
compression paradigms, or the equivalent time point during the
placebo condition.
Compression System
Our custom-made compression system (Figure 2) utilized rapid
inflation and deflation rates (<1 s) to deliver the intermittent
compression intervention at pressures of 0–30 and 0–60 mmHg.
We attached a pressure regulator to a pressure source that
allowed us to control the pressure in the cuff. Throughout testing,
a pressure transducer (Reusable BP Transducer MLT0380/D,
ADInstruments, Colorado Springs, CO, United States) was
used to monitor compression pressures within the inflatable
compression garments and confirmed that target pressures were
successfully applied.
FIGURE 2 | Compression system. The compression system encompassed a
pressure regulator, a pressure source, a valve control box and two
compression cuffs (adult large), shown above from left to right. The pressure
source was connected to a valve control box with an Arduino board and
programmable Arduino chip, which allowed us to program the valve system to
cycle from open for 4 s to closed for 11 s throughout the test. In addition, the
pressure inside one of the compression cuffs was continuously monitored
throughout testing with the use of a pressure transducer.
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Data and Statistical Analyses
Analyses were performed by investigators blinded to the test
condition. Cardiovascular data are represented as mean values
over the final 30 s of every 2 min period for the duration
of each tilt test. Calf circumference data derived from strain
gauges are reported as percent changes from supine and are
similarly presented as 30 s means [during the compression-free
(off) phase during intermittent compression paradigms, or the
equivalent time point during the placebo condition] at 2 min
intervals throughout each tilt. Strain gauge data from the level
of maximum calf circumference and gaiter region were averaged
for the right and left legs. Supine values (time point zero) for
both cardiovascular and strain gauge data were calculated as
mean values over the final 30 s of the final minute of the
supine period. Absolute FVR data are influenced by the angle
of insonation of the brachial ultrasound probe, which could not
be standardized between participants, therefore these data are
reported only as the percent change from baseline. However, the
angle of insonation was maintained within each participant, so
evaluations of the percent changes in FVR within the protocol
are valid. In theory, measures of FVR would be unreliable if
the diameter of the insonated vessel changed during testing.
However, we previously confirmed that there is no change in
brachial arterial diameter with this level of orthostatic stress,
because resistance responses occur in downstream arterioles,
and accordingly that changes in velocity are proportional to
flow (Claydon et al., 2019). We used nasal sampling to measure
PETCO2 because it is more comfortable and allows the participant
to communicate symptoms throughout testing. However, one
caveat of nasal sampling is that some mixing with room air can
occur, depending on the placement of the nasal prong, resulting
in slightly lower PETCO2 values (∼3–5 mmHg), although the
changes over time are consistent within a placement position.
Accordingly, PETCO2 values are also reported only as the
change from baseline.
Statistical analyses and data visualization were performed
using JMP R© (Version 14.1, SAS Institute Inc., Cary, NC,
United States) and SigmaPlot (Version 14 Systat Software, Inc,
San Jose, CA, United States). We tested data for normality using
the Shapiro–Wilk test and data are reported as means ± SEM.
Differences were determined to be statistically significant where
p < 0.05. For the orthostatic tolerance outcomes, we performed
a linear mixed model analysis with a Tukey HSD post hoc test,
a Kaplan–Meier time-to-event Analysis (Gehan–Breslow test),
as well as a paired t-test on the change in orthostatic tolerance
between ICLF conditions and placebo data. To test whether
intervention order had an effect on orthostatic tolerance, we
ran a linear mixed model analyses with compression condition
and intervention order as factors. For cardiovascular and venous
pooling data, comparisons between tilt conditions and over time
were conducted using linear mixed model analyses with a Tukey
HSD post hoc test.
We performed correlations between changes in venous
pooling and capillary filtration during orthostatic stress with
baseline calf circumference or MCSA using the Pearson
correlation coefficient.
RESULTS
Of our 21 participants, 18 were included in the analysis
of orthostatic tolerance data. To ensure a complete repeated
measures analysis, we excluded individuals who were missing
a tilt endpoint in one of the three conditions. One individual
was excluded due to technical difficulties with the ICLF in the
0–30 mmHg condition, one individual elected to stop the test
early prior to reaching endpoint criteria in the 0–60 mmHg
condition, and one individual chose not to return for the 3rd
test (0–60 mmHg condition). All 21 individuals were included in
secondary analyses of cardiovascular and plethysmographic data.
Orthostatic Tolerance
Orthostatic tolerance results are shown in Figure 3. Orthostatic
tolerance (time to presyncope) was significantly improved with
0–60 mmHg (33 ± 2.2 min) ICLF, compared to both the placebo
(26 ± 2.4 min; p = 0.0009) and 0–30 mmHg (25 ± 2.7 min;
p = 0.0007) conditions; however, 0–30 mmHg ICLF showed no
benefit over the placebo condition (p = 0.9921) (Figure 3A).
There was no effect of intervention order on orthostatic tolerance
(p = 0.763) and no interaction between compression condition
and intervention order (p = 0.977). Kaplan–Meier time-to-event
analyses (Figure 3B) similarly showed that time to presyncope
was significantly delayed in the 0–60 mmHg condition compared
to both the placebo (p = 0.0388) and 0–30 mmHg (p = 0.0442)
conditions. The mean improvement in orthostatic tolerance from
placebo with 0–60 mmHg ICLF was +7.4 ± 1.8 min; this was
significantly greater than the mean change from placebo with
0–30 mmHg ICLF (−0.2 ± 1.6 min; p < 0.001; Figure 3C).
The mean improvement in orthostatic tolerance was dependent
on orthostatic tolerance in the placebo condition (r = −0.519;
p = 0.0229), such that individuals with a lower baseline or placebo
orthostatic tolerance experienced a greater improvement with 0–
60 mmHg ICLF (Figure 3D). One caveat of this result is that tests
in the 0–60 mmHg condition were more likely to be terminated at
participant request due to symptoms and discomfort associated
with the high levels of orthostatic stress or due to orthostatic
tachycardia, rather than a presyncopal blood pressure drop. In
the placebo condition 86% of tilts were terminated because of
presyncope (vasovagal response), versus 85% with 0–30 mmHg
ICLF and 60% with 0–60 mmHg ICLF (χ2: p = 0.043). In
both the placebo and 0–30 mmHg ICLF conditions 5% of tilts
were terminated due to orthostatic tachycardia with symptoms,
compared to 10% of tilts in the 0–60 mmHg ICLF condition. With
0–60 mmHg ICLF 30% of tilts were terminated at participant
request due to orthostatic symptoms alone, versus 10% of tilts
in each of the placebo and 0–30 mmHg ICLF conditions. MCSA
was not related to the magnitude of improvement in orthostatic
tolerance in either ICLF condition (0–30 mmHg: r = −0.265,
p = 0.258; 0–60 mmHg: r =−0.318, p = 0.184).
Venous Pooling and Filtration
Changes in calf and gaiter circumference over the course of the tilt
test are shown in Figure 4. Data are shown up until the end of the
first phase of LBNP, because in the placebo and 0–30 mmHg ICLF
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FIGURE 3 | Orthostatic tolerance. (A) Orthostatic tolerance, rounded to the nearest minute, is shown for all three tilt conditions. (B) Kaplan–Meier plot depicting the
proportion of participants remaining (who have not reached presyncope) in each condition at any given tilt time. (C) Bar plots showing the mean improvement in
orthostatic tolerance for each compression condition relative to the placebo. (D) The mean improvement in orthostatic tolerance with 0–60 mmHg compression
compared to placebo was dependent on baseline orthostatic tolerance (placebo). *Significantly different from placebo (p < 0.05); †significantly different from 0 to
30 mmHg compression (p < 0.05). Shaded gray boxes of increasing intensity represent stages of the tilt test and increasing orthostatic stress. OT, orthostatic
tolerance.
conditions only one person was able to tolerate the subsequent
phase(s). Both the 0–30 mmHg (p = 0.0005) and 0–60 mmHg
(p < 0.0001) ICLF conditions significantly reduced pooling and
filtration at the level of the calf compared to placebo; however,
the 0–60 mmHg ICLF additionally outperformed 0–30 mmHg
ICLF (p < 0.0001). After 20 min of HUT, calf circumference
increased by+0.48± 0.30% in the placebo condition, which was
significantly greater than 0–60 mmHg ICLF (−0.57 ± 0.27%;
p = 0.0162), but was not different from 0–30 mmHg ICLF
(+0.17± 0.31%).
At the level of the gaiter, edema distal to the site of
compression was not exacerbated with ICLF and, in fact, was
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FIGURE 4 | Venous pooling and capillary filtration during tilt testing. The time course of pooling and filtration in the calf (A) and at the level of the gaiter (B). Data are
presented as a percentage change form supine and symbols (mean ± SEM) reflect mean data from the right and left calves/gaiters combined, from the final 30 s of
every 2 min interval. Main effects of condition throughout tilt are shown. *Significantly different from placebo (p < 0.001); †Significantly different from 0 to 30 mmHg
compression. BL, baseline; HUT, head-upright tilt; LBNP, lower body negative pressure.
reduced. With 0–60 mmHg ICLF gaiter circumference was
reduced compared to both 0–30 mmHg ICLF (p < 0.0001)
and placebo (p = 0.0058). With 0–30 mmHg ICLF, gaiter
circumference was not different from placebo (p = 0.1667).
There was a main effect of tilt time elapsed on pooling and
filtration at the level of the gaiter (p < 0.0001), with pooling
and filtration increasing over the course of tilt. After 20 min of
HUT, gaiter circumference increased by +0.27 ± 0.11% in the
placebo condition, by+0.33± 0.19% with 0–30 mmHg ICLF, and
by +0.15 ± 0.31% with 0–60 mmHg ICLF compared to supine
baseline; these were not statistically significant.
Anthropometric calf circumference measurements and
calculated MCSA were not related to the magnitude of pooling at
the level of the calf or the gaiter after 20 min of HUT in any of
the three conditions.
Cardiovascular Responses
Supine cardiovascular parameters were similar between
compression conditions (Table 1). The time course of
cardiovascular responses throughout tilt in the three compression
conditions are shown in Figures 5, 6, with main effects of
condition indicated. Data are shown up until the end of the
first phase of LBNP, because in the placebo and 0–30 mmHg
ICLF conditions only one person was able to tolerate the
subsequent phase(s). The absolute and percent changes from
baseline values for each parameter are shown in Table 1
for key stages of the test: baseline, after 10 min of tilting
(Tilt10), after 20 min of tilting (Tilt20), at the end of the first
phase of LBNP (LBNP30), and at the presyncope time point,
with effects of condition and time indicated. Note that for
percent changes, differences between these stages and baseline
values are not represented, as the baseline is without variance
(0.00± 0.00%).
Overall, SAP (Figure 5A and Table 1) was significantly
increased during tilt with both 0–30 mmHg (p = 0.0001) and
0–60 mmHg (p < 0.0001) ICLF compared to placebo, and with
0–60 mmHg ICLF compared to 0–30 mmHg ICLF (p = 0.0348).
When data were expressed as a percent change from baseline,
SAP was only increased with 0-60 mmHg ICLF compared to
placebo (p = 0.0421). At presyncope, SAP was not significantly
different between conditions, although it was reduced compared
to baseline, Tilt10, Tilt20, and LBNP30 time points in all three
conditions (p < 0.0001). Throughout tilt, DAP (Figure 5A and
Table 1) was significantly higher in the 0–60 and 0–30 mmHg
ICLF conditions compared to placebo (p < 0001). When data
were expressed as a percentage change from baseline, DAP was
increased with 0–60 mmHg ICLF compared to 0–30 mmHg
ICLF (p = 0.0496), but ICLF conditions were not different
from placebo. In all three conditions, DAP tended to increase
during the tilt test compared to baseline. At presyncope, DAP
was reduced compared to baseline, Tilt10, Tilt20, and LBNP30
time points in the placebo and 0–30 mmHg ICLF conditions
(p < 0.0001). With 0–60 mmHg ICLF DAP was reduced at
presyncope compared to Tilt10, Tilt20, and LBNP30 time points
(p < 0.0001), but was not different from baseline (p = 0.3780).
DAP tended to be higher at presyncope in the 0–60 mmHg
condition compared to placebo (p = 0.0577) and 0–30 mmHg
ICLF (p = 0.1023).
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TABLE 1 | Cardiovascular responses at selected tilt intervals.
Baseline Tilt10 1(%) Tilt20 1(%) LBNP30 1(%) Presyncope 1(%)
SAP (mmHg) Placebo 117.8 ± 2.8 122.8 ± 3.4 2.8 ± 2.0 124.3 ± 4.2 4.4 ± 2.8 115.7 ± 4.6 −5.0 ± 3.5 74.9 ± 3.1*†‡ −36.4 ± 2.1†‡
0–30 mmHg 120.5 ± 2.5 128.8 ± 4.0 5.0 ± 2.3 123.5 ± 5.1 5.0 ± 2.3 123.4 ± 8.3 −0.5 ± 5.1 74.7 ± 3.0*†‡ −38.1 ± 2.1†‡
0–60 mmHg 123.4 ± 2.6 125.9 ± 2.9 2.2 ± 1.9 128.5 ± 3.4 3.5 ± 2.2 125.7 ± 3.4 −1.8 ± 3.0 85.4 ± 4.0*†‡ −30.5 ± 3.3†‡
DAP (mmHg) Placebo 66.9 ± 1.8 77.6 ± 1.8* 13.7 ± 2.4 78.3 ± 2.6* 15.3 ± 2.8 78.0 ± 3.2 11.7 ± 2.9 53.3 ± 2.6*†‡ −20.3 ± 3.1†‡
0–30 mmHg 69.2 ± 2.0 81.1 ± 2.4* 15.0 ± 1.6 79.4 ± 2.4 11.3 ± 2.4 82.2 ± 4.5 15.0 ± 3.8 53.3 ± 3.2*†‡ −23.0 ± 2.1†‡
0–60 mmHg 69.5 ± 1.6 78.4 ± 1.7 13.2 ± 2.1 80.3 ± 1.9* 14.8 ± 2.1 81.5 ± 1.6 13.8 ± 2.9 62.6 ± 3.5†‡ 10.2 ± 4.2†‡β
HR (bpm) Placebo 63.3 ± 2.3 84.1 ± 3.2* 34.2 ± 2.8 84.8 ± 3.1* 35.7 ± 3.9 102.4 ± 6.6*†‡ 77.9 ± 9.2†‡ 118.8 ± 5.9*†‡ 89.9 ± 10.2†‡
0–30 mmHg 63.2 ± 2.7 84.1 ± 4.0* 34.3 ± 4.4 81.0 ± 4.4 27.9 ± 3.8 103.9 ± 9.5*‡ 67.6 ± 11.5‡ 113.1 ± 7.3*†‡ 80.2 ± 10.6†‡
0–60 mmHg 61.2 ± 2.4 78.8 ± 3.6* 28.8 ± 3.4 80.0 ± 3.3* 30.4 ± 3.4 93.3 ± 6.8* 54.2 ± 5.5 121.5 ± 6.9*†‡ 98.5 ± 10.3†‡
SV (mL) Placebo 90.7 ± 3.6 69.6 ± 3.8* −25.0 ± 2.1 70.0 ± 3.6* −25.9 ± 2.0 54.9 ± 5.0*†‡ −43.5 ± 3.1†‡ 33.0 ± 2.0*†‡ −63.0 ± 2.2†‡
0–30 mmHg 89.3 ± 4.3 68.6 ± 4.7* −26.3 ± 2.5 68.1 ± 5.0* −26.5 ± 2.7 54.3 ± 8.2* −43.3 ± 5.1†‡ 35.0 ± 2.7*†‡ −59.9 ± 2.8†‡
0–60 mmHg 98.5 ± 4.0 78.4 ± 5.2* −21.3 ± 3.3 75.3 ± 4.4* −24.7 ± 2.0 66.4 ± 7.4* −36.6 ± 4.7†‡ 34.5 ± 2.7*†‡ −65.0 ± 2.5†‡
CO (L∗min−1) Placebo 5.72 ± 0.30 5.76 ± 0.32 −0.52 ± 2.0 5.86 ± 0.33 −0.7 ± 2.3 5.39 ± 0.33 −1.86 ± 3.2 3.84 ± 0.26*†‡ −32.2 ± 4.1†‡
0–30 mmHg 5.63 ± 0.33 5.55 ± 0.35 −3.4 ± 4.3 5.29 ± 0.38 −7.2 ± 4.1 5.19 ± 0.45 −6.7 ± 7.1 3.76 ± 0.26*†‡ −29.8 ± 6.1†‡
0–6 0mmHg 6.00 ± 0.32 5.93 ± 0.32 −0.11 ± 3.4 5.84 ± 0.32 −2.1 ± 3.7 5.72 ± 0.45 −4.5 ± 6.1 4.09 ± 0.32*†‡ −32.3 ± 4.0†‡
TPR Placebo 15.5 ± 0.8 17.2 ± 1.1 10.0 ± 3.1 17.0 ± 1.2 10.0 ± 3.1 17.6 ± 1.3 8.0 ± 5.6 17.8 ± 1.1 18.6 ± 6.7
(mmHg∗min∗L−1) 0–30 mmHg 16.4 ± 0.9 18.8 ± 1.3 17.0 ± 5.6 19.2 ± 1.5 17.8 ± 6.3 19.9 ± 2.0 17.8 ± 6.3 18.1 ± 1.5 17.5 ± 14.4
0–60 mmHg 16.2 ± 1.1 16.8 ± 0.9 7.5 ± 4.5 17.6 ± 1.0 12.8 ± 6.0 18.3 ± 1.4 17.2 ± 7.6 19.5 ± 1.7 25.0 ± 9.5
FVR Placebo – – 82.3 ± 27.4 – 90.5 ± 27.0 – 152.9 ± 54.2 – 72.1 ± 23.3
(mmHg∗min∗L−1) 0–30 mmHg – – 122.6 ± 35.9 – 63.6 ± 20.2 – 118.5 ± 35.7 – 59.1 ± 25.5‡
0–60 mmHg – – 83.5 ± 18.4 – 72.4 ± 13.6 – 99.0 ± 32.2 – 210.0 ± 50.6†‡αβ
CBFv (cm∗s−1) Placebo 61.0 ± 4.7 39.9 ± 4.4* −36.3 ± 2.8 40.2 ± 4.3* −35.8 ± 2.8 30.5 ± 6.1* −54.8 ± 4.3†‡ 22.5 ± 2.4*†‡ −62.4 ± 3.2†‡
0–30 mmHg 61.8 ± 5.3 39.1 ± 4.9* −37.4 ± 4.2 41.6 ± 5.7* −35.4 ± 3.3 27.4 ± 4.1* −51.0 ± 5.3 25.0 ± 3.2*†‡ −61.4 ± 3.1†‡
0–60 mmHg 64.2 ± 6.2 44.7 ± 4.7* −28.3 ± 4.0 41.8 ± 3.6* −31.0 ± 4.1 37.0 ± 4.8* −40.5 ± 3.9† 22.3 ± 3.1*†‡ −63.7 ± 2.6†‡
PETCO2 (mmHg) Placebo – – −14.2 ± 2.6 – −12.2 ± 3.2 – −20.8 ± 3.0 – −29.4 ± 3.5†‡
0–30 mmHg – – −14.0 ± 2.0 – −14.4 ± 2.0 – −27.2 ± 5.4 – −31.4 ± 3.4†‡
0–60 mmHg – – −10.2 ± 2.8 – −11.5 ± 2.4 – −18.6 ± 2.1 – −28.1 ± 4.0†‡
Data are presented as the mean ± SEM for each condition with percent changes from baseline indicated in shaded columns. Main effects of condition are not shown. Note that for percent changes, statistical differences
relative to baseline values are not represented, as the baseline is without variance (0.00 ± 0.00%). Symbols: *Significantly different from baseline value for given condition; †Significantly different from 10 min time point
for given condition (Tilt10). ‡Significantly different from 20 min time point for given condition (Tilt20). Significantly different from the end of the first phase of LBNP for given condition (LBNP30). SAP, systolic arterial
pressure; DAP, diastolic arterial pressure; HR, heart rate; SV, stroke volume; CO, cardiac output; TPR, total peripheral resistance; FVR, forearm vascular resistance. αSignificantly different from placebo condition at given
time point. βSignificantly different from 0 to 30 mmHg compression condition at given time point.
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FIGURE 5 | Blood pressure and heart rate responses during tilt testing. The time course of blood pressure (A) and heart rate (B) during tilt are shown. Symbols
(mean ± SEM) reflect averaged data, over the last 30 s of every 2 min interval. Main effects of condition throughout tilt are shown. *Significantly different from
placebo (p < 0.001); †Significantly different from 0 to 30 mmHg compression. BP, blood pressure; SAP, systolic arterial pressure; DAP, diastolic arterial pressure; HR,
heart rate; BL, baseline; HUT, head-upright tilt; LBNP, lower body negative pressure.
HR (Figure 5B and Table 1) increased during tilt (Tilt10,
Tilt20, LBNP30 and presyncope time points) compared to
baseline supine in the placebo and 0–60 mmHg ICLF conditions
(p < 0.03). With 0–30 mmHg ICLF HR was increased compared
to baseline at Tilt10, LBNP30 and presyncope time points
(p < 0.01), but was not significant at Tilt20 (p = 0.1298).
Throughout tilt, HR remained significantly lower in the
0–60 mmHg ICLF condition, compared to both placebo
(p < 0.0001) and 0–30 mmHg ICLF (p = 0.0005). Furthermore,
HR remained lower with 0–30 mmHg ICLF compared to placebo
(p = 0.0404). When expressed as a percent change from baseline,
the magnitude of the HR increase was significantly blunted
with 0–60 mmHg ICLF relative to placebo (p < 0.0001) and
0–30 mmHg ICLF (p = 0.0005) and tended to be reduced
with 0–30 mmHg ICLF compared to placebo (p = 0.0512).
At presyncope, the magnitude of the HR increase (%) was
significantly greater compared to Tilt10 and Tilt20 time points
in all three conditions (p < 0.0001), but was only significantly
greater than LBNP30 in the 0–60 mmHg compression condition
(p< 0.0001).
In all three compression conditions, SV (Figure 6A and
Table 1) was significantly reduced during tilt (Tilt10, Tilt20,
LBNP30, and presyncope) compared to baseline supine
(p ≤ 0.0003). SV remained significantly higher with 0–60 mmHg
compression compared to placebo (p< 0.0001) and 0–30 mmHg
ICLF (p < 0.0001). When expressed as a percent change from
baseline, the magnitude of the SV reduction associated with
tilt was decreased with 0–60 mmHg ICLF relative to placebo
(p = 0.0001) and 0–30 mmHg ICLF (p = 0.0001).
During tilt (Tilt10, Tilt20, and LBNP30), CO (Figure 6B and
Table 1) was not different from baseline supine, irrespective
of condition. Overall, CO was higher in the 0–60 mmHg
compression condition compared to 0–30 mmHg (p < 0.0001)
and placebo (p< 0.0001), and was increased in placebo compared
to 0–30 mmHg ICLF (p = 0.0074). However, when expressed as
a percent change from baseline, CO was not different between
conditions. At presyncope CO was reduced compared to baseline,
Tilt10 and Tilt20 time points in all three conditions (p < 0.0028),
but was only also reduced compared to LBNP30 in the placebo
and 0–60 mmHg conditions (p< 0.0013).
During tilt (Tilt10, Tilt20, and LBNP30) and at presyncope,
TPR (Table 1) was not different from baseline supine, irrespective
of condition. Overall, TPR (absolute value or percent change
from baseline) was increased in the 0–30 mmHg compression
condition compared to both placebo (p ≤ 0.0300) and 0–
60 mmHg ICLF (p ≤ 0.0125).
FVR (Table 1; reported only as percent change from
baseline as noted previously) was not different between
compression conditions throughout tilt. However, at presyncope,
FVR was significantly greater in the 0–60 mmHg ICLF
condition compared to placebo (p = 0.009) and 0–30 mmHg
ICLF (p = 0.002), perhaps again reflecting that the test
was stopped in some individuals in the 0–60 mmHg ICLF
condition due to orthostatic symptoms or HR criteria, rather
than presyncope.
For all conditions, CBFv (Figure 6C and Table 1) decreased
during tilt (Tilt10, Tilt20, and LBNP30; p < 0.0001) and at
presyncope (p < 0.0001) relative to baseline. Throughout tilt,
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FIGURE 6 | Stroke volume, cardiac output, cerebral blood flow velocity and end-tidal CO2 responses during tilt testing. The time course of stroke volume (A),
cardiac output (B), cerebral blood flow velocity (C) and end-tidal carbon dioxide (D) during tilt are shown. Symbols (mean ± SEM) reflect averaged data, over the
last 30 s of every 2 min interval and are reported as a percentage change from supine values. Main effects of condition throughout tilt are shown. *Significantly
different from placebo (p < 0.001); †significantly different from 0 to 30 mmHg compression. SV, stroke volume; CO, cardiac output; CBFv, cerebral blood flow
velocity; PETCO2, end tidal partial pressure of carbon dioxide; BL, baseline; HUT, head-upright tilt; LBNP, lower body negative pressure.
CBFv (absolute value or percent change from baseline) remained
higher with 0–60 mmHg ICLF compared to both 0–30 mmHg
ICLF (p< 0.0001) and placebo (p< 0.0001).
Throughout tilt, PETCO2 (Figure 6D and Table 1) was
significantly increased with 0–60 mmHg compression compared
to both placebo (p< 0.0001) and 0–30 mmHg ICLF (p< 0.0001).
At presyncope, PETCO2 was significantly reduced compared to
Tilt10 and Tilt20 values for all conditions (p ≤ 0.0001), but was
not different from LBNP30.
Initial Systolic Arterial Pressure
Responses
We evaluated the effect of intermittent compression on SAP
throughout the initial 30 s of tilt to examine whether this
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intervention might be of benefit for the prevention of initial
orthostatic hypotension (OH). For each participant we expressed
SAP as an absolute change from baseline values (Figure 7A),
and subsequently integrated the area of the SAP curve that
fell below baseline during the initial 30 s of tilt for each
condition (Figure 7B). Only participants with complete data
from all three tilts were included in the analysis (n = 17).
The cumulative sum of the integrated area for all participants
throughout the first 30 s is shown in Figure 7C, and
illustrates that ICLF, particularly 0–60 mmHg ICLF, tends to
blunt the initial blood pressure drop associated with upright
tilt. We compared the cumulative summed area of the SAP
decrement between conditions using a linear mixed model
analysis (Figure 7D), which showed that 0–60 mmHg ICLF
tends to reduce the SAP drop compared to placebo (p = 0.052),
whereas 0–30 mmHg ICLF is not sufficient to blunt the
initial orthostatic SAP drop (p = 0.203). Three participants
met criteria for initial OH (SAP decrease ≥ 40 mmHg or
DAP decrease ≥ 2 0 mmHg within 15 s of standing) in the
placebo condition, while one participant met criteria in the
0–60 mmHg condition, and none met the criteria in the 0–
30 mmHg condition.
DISCUSSION
In this study, we demonstrated that intermittent calf compression
from 0 to 60 mmHg (4 s on – 11 s off) effectively delays the onset
of presyncope in healthy individuals. Our 0–60 mmHg ICLF
paradigm successfully prevented venous pooling and capillary
FIGURE 7 | Systolic arterial pressure (SAP) reduction in the initial 30 s of head-up tilt. For each participant, the area of the SAP curve that dipped below baseline
values throughout the first 30 s of HUT was integrated for each condition. The area under the curve of the SAP dip for was summed for each participant in each
condition. (A) A sample trace from one participant showing the SAP time course in the first 30 s of tilt in the three conditions. (B) The integrated area between the
baseline and SAP curves in each of the three conditions for the same sample participant. (C) The cumulative summed area for all participants in each of the three
compression conditions throughout the first 30 s of tilt. (D) Boxplots comparing the cumulative summed area between the baseline and SAP curves for each
participant in the three conditions. Solid lines show the sample median, while dashed lines depict the sample mean.
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filtration in the calf, even reducing fluid accumulation relative to
supine baseline (Kitayama et al., 2017; Tran and Argáez, 2017).
This fluid was instead mobilized back into the effective circulating
volume, perhaps with some enhancement in lymphatic drainage,
improving SV, allowing blood pressure to be maintained at
a reduced HR, and thus increasing cardiovascular autonomic
reserve, improving CBFv, and delaying presyncope. The 0–
60 mmHg ICLF outperformed both placebo and 0–30 mmHg
ICLF in these respects. In this study, a smaller proportion of
tilts were terminated due to presyncopal blood pressures in the
0–60 mmHg ICLF condition than with placebo or 0–30 mmHg
ICLF. These tilts were instead terminated at participant request
due to orthostatic symptoms at these high levels of orthostatic
stress or due to orthostatic tachycardia; therefore, it is possible
that the mean improvement in orthostatic tolerance of +7.4 min
we observed with 0–60 mmHg ICLF may underestimate the true
benefit of this intervention had these tests been continued until a
presyncopal end point was reached in all participants. Regardless,
an improvement in orthostatic tolerance of this magnitude,
during profound orthostatic stress (tilting combined with LBNP)
is a large and clinically meaningful improvement in orthostatic
tolerance, comparable to that of salt supplementation, water
ingestion and head-upright sleeping (Cooper and Hainsworth,
2002, 2008; Schroeder et al., 2002; Lu et al., 2003; Claydon and
Hainsworth, 2004; Claydon et al., 2006).
We chose to also test ICLF at the level of 0–30 mmHg
to examine whether there would be a dose-dependent effect
on orthostatic tolerance, and also because if a lower pressure
offers benefit, this would simplify device engineering. Our
previous studies showed that pressures lower than 60 mmHg
were sufficient to blunt pooling in the calf, but did not convey
a measurable cardiovascular benefit during a short (10 min)
orthostatic challenge (Hockin et al., 2019). We wondered whether
reduced pooling would be sufficient to delay syncope in the face
of a more severe orthostatic stress. Although 0–30 mmHg ICLF
did indeed blunt venous pooling and capillary filtration in the
calf, this pressure was not sufficient to produce a meaningful
hemodynamic benefit, similar to our previous studies, and did
not improve orthostatic tolerance compared to placebo.
In addition to the improved SV and HR responses we observed
during the test, 0–60 mmHg ICLF was also associated with
increased CBFv and PETCO2. During profound orthostatic stress,
the body engages the respiratory muscle pump to enhance
venous return, with individuals experiencing a drive to increase
breathing rate and depth (Miller et al., 2005). During deep
inspiration, decreased intrathoracic pressure is transmitted to the
cardiac chambers and thoracic blood vessels, creating a pressure
gradient that promotes right atrial filling and venous return.
Intra-abdominal pressure increases simultaneously, compressing
both the iliac and femoral veins, reducing retrograde flow
and further supporting an increased venous return (Miller
et al., 2005). One negative consequence of activation of the
respiratory muscle pump is that the increased ventilation
decreases circulating CO2. CO2 is a potent vasodilator in the
cerebral circulation, so the reduction in circulating CO2 results in
decreased CBFv (Norcliffe-Kaufmann et al., 2008). The improved
CBFv we observed with 0–60 mmHg ICLF in the present study
appears to be largely due to decreased activation of the respiratory
muscle pump, as the reduction in PETCO2 levels associated
with tilting was blunted compared to placebo and 0–30 mmHg
ICLF (Figure 6D and Table 1). This is further evidence that
intermittent calf compression increases hemodynamic reserve
during orthostatic stress.
For intermittent calf compression to work effectively, both
0 mmHg holding pressures and rapid inflation rates are key.
A 0 mmHg holding pressure allows the veins to fill between
pulses, which is necessary for the venous pump to work
effectively, and further prevents the formation of edema distal to
the site of compression (Rucinkski et al., 1991; Lurie et al., 2003).
Rapid inflation rates optimize venous return by maximizing peak
flow velocities (Morris et al., 2006).
We chose to evaluate the ICLF interventions using head-up
tilting rather than motionless standing for several reasons: (1) it
allows the level of muscle activation to be standardized across all
conditions; (2) it permits calf circumference to be measured using
strain gauge plethysmography without artifact due to postural
sway; (3) head-up tilting is a more intense orthostatic stress
than active standing, and when combined with LBNP enables
the achievement of a presyncopal end-point in the majority
of participants.
To evaluate venous pooling and capillary filtration,
we measured calf circumference using strain gauge
plethysmography; this approach is well established (Whitney,
1953; Gamble et al., 1993; Halliwill et al., 1999; Rosfors et al.,
2014; Oeffinger et al., 2015). Upon assuming an upright posture,
predictable fluid shifts are known to occur in the legs, with a
rapid (∼2 min) pooling phase and a slower (>2 min) filtration
phase (Brown and Hainsworth, 1999). Our calf circumference
data suggest that venous pooling may have been slightly blunted
by the presence of the compression cuff wrapped around the
calf, as calf circumference in the rapid pooling phase (2 min) in
the placebo condition are lower here than in previous studies
(Brown and Hainsworth, 1999; Hockin et al., 2019). After 10 min
of 60◦ HUT, accrued pooling and filtration has been shown to
be ∼100 mL in each calf (Brown and Hainsworth, 1999) thus
we expect by preventing venous pooling with 0–60 mmHg ICLF,
that ∼200 mL of fluid was mobilized back into the effective
circulating volume. We monitored gaiter circumference to
ensure that our intervention did not trigger edema distal to the
site of compression. In this respect, we regard that the 0 mmHg
holding pressure is crucial.
We considered the impact baseline calf circumference or
MCSA might have on venous pooling and filtration and on
the efficacy of 0–60 mmHg ICLF. There were no significant
relationships between baseline calf circumference or MCSA and
measures of venous pooling and filtration, or the efficacy of the
intermittent compression paradigm at 0–60 mmHg. Accordingly,
these findings suggest that the efficacy of intermittent calf
compression is not limited by anthropometric calf measures.
We also considered whether baseline orthostatic tolerance
influenced the efficacy of 0–60 mmHg ICLF to delay the onset
of presyncope. The mean improvement in orthostatic tolerance
was dependent on the placebo condition orthostatic tolerance,
such that individuals with a lower baseline orthostatic tolerance
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experienced a greater benefit with 0–60 mmHg ICLF. The caveat
of this relationship is that a smaller proportion of tests in
the 0–60 mmHg ICLF condition were terminated due to true
presyncope, determined as a SAP < 80 mmHg, so the true
improvement in orthostatic tolerance, particularly at the extreme
levels of orthostatic stress tolerated in the 0–60 mmHg may be
underestimated. Furthermore, it is far more difficult to improve
orthostatic tolerance when baseline orthostatic tolerance is
already in excess of the normal range (in the −40 or −60 mmHg
phases of LBNP where the orthostatic stress is severe) – there
may be a ceiling effect beyond which further improvements in
already exceptional orthostatic tolerance are more limited. This
does not limit the implications of this intervention – those with
the poorest orthostatic tolerance would be the target for such a
device, and are also those most able to exploit use of ICLF to
improve their orthostatic cardiovascular control and delay the
onset of presyncope during orthostatic stressors.
Despite testing this intervention in a healthy population, these
results are encouraging for the management of recurrent syncope,
and likely underestimate the benefit we would see in a patient
population. Previous studies have shown that patients with
syncope experience exacerbated venous pooling and capillary
filtration, and have an increased cerebral reactivity to hypocapnia
(Norcliffe-Kaufmann et al., 2008). With 0–60 mmHg ICLF, the
prevention of pooling was robust, even with very high intensity
orthostatic stress, supporting the notion that this pressure would
also be sufficient to prevent pooling in patient populations.
In patients with excessive pooling, the hemodynamic benefit
would likely be increased, as a greater volume of fluid would
be mobilized back into circulation. In this respect, the effect
on orthostatic blood pressure control would presumably be
greater than we observed here in healthy controls, who defend
their blood pressure effectively during orthostasis. As previously
mentioned, the fall in PETCO2 associated with tilt was blunted
with 0–60 mmHg ICLF due to reduced activation of the
respiratory muscle pump; this would be beneficial in patients
with an increased sensitivity to hypocapnia, increasing CBFv and
reducing symptoms of presyncope. In light of these favorable
results, future studies are recommended to confirm the utility of
this intervention in patient populations.
The benefits of this intervention are not limited to patients
with orthostatic syncope secondary to hypotension (vasovagal
or OH); intermittent calf compression could also be an
effective option for patients with orthostatic intolerance due
to Postural Orthostatic Tachycardia Syndrome (POTS). POTS
patients exhibit excessive HR responses during orthostasis, and
experience considerable reductions in CBFv, which are largely
due to postural hypocapnic hyperventilation (Novak et al., 1998;
Del Pozzi et al., 2014). Patients report palpitations, fatigue, “brain
fog,” and experience symptoms of presyncope while upright.
Based on our results, intermittent calf compression would be
expected to reduce sympathetically-mediated increases in HR
and improve CBFv for these patients, reducing symptoms and
improving quality of life. Furthermore, our analysis of initial
SAP responses suggest that this intervention would be valuable
in mitigating initial OH. We showed that 0–60 mmHg ICLF
tends to blunt the initial decrease in SAP within the first 30 s
of tilting. This is particularly important because in the present
study we activated the compression upon tilting. It is possible
that activation of the intermittent compression paradigm a few
seconds prior to tilting would have provided further benefit.
Because the management of recurrent syncope is challenging,
with limited benefit from pharmacological therapies, there
is a need for novel therapeutic approaches. Consequently,
other research groups are also exploring the utility of active
compression. Moein et al. (2017) evaluated the efficacy of
an active calf compression brace on orthostatic cardiovascular
responses. The brace, when wrapped around the calf, exerted
a baseline counterpressure of 15 mmHg, and utilized shape
memory alloys that could be actuated to apply a pressure up
to 27 mmHg (Moein et al., 2017). During tilting, actuation
of the brace improved SV and HR responses (Moein et al.,
2017). Okamoto et al. (2016) evaluated the efficacy of a servo-
controlled inflatable abdominal binder for the reduction of
splanchnic venous pooling during active standing in patients with
autonomic failure. The binder could be inflated to a pressure
of 40 mmHg during active standing and was as effective as
Midodrine at improving upright BP and reducing orthostatic
symptoms (Okamoto et al., 2016). These groups have shown that
their compression garments improve hemodynamic responses
during short bouts of orthostasis, but have not yet shown that
they can delay the onset of presyncope. Both of these novel
compression garments are active in the sense that they can be
actuated during standing, when the compression is needed, to
limit venous pooling, but are then static as the compression
pressure applied is constant. The mechanism of intermittent calf
compression differs from these garments, as the intermittent
nature of the compression mimics the skeletal muscle pump to
enhance venous return, rather than simply preventing venous
pooling. We expect that intermittent compression of the calf
may have a comfort advantage over actuated compression as
intermittent compression promotes venous return, preventing
stagnancy and an associated build up of metabolites.
With the success of our intermittent calf compression
paradigm at delaying the onset of presyncope, we anticipate that
this study will be instrumental in the design and production
of a “smart” ambulatory intermittent compression device. We
envision that this device would rapidly (<1 s) engage, applying
4 pulses at 0–60 mmHg of pressure per minute (4 s on – 11 s off).
The device might utilize dielectric elastomer actuators (Pourazadi
et al., 2015) or shape memory alloys (Moein and Menon,
2014; Moein et al., 2017) to enable intermittent compression,
and would contain accelerometers, allowing compression to be
activated during motionless standing and deactivated during
ambulation (when the skeletal muscle pump helps offset
hemodynamic deficits) or during sitting/supine postures (when
orthostatic stress is negligible), incorporated into a comfortable
and portable garment.
Limitations
This experiment was conducted in a single-blind fashion; the
investigator that terminated the test was unaware of the study
condition during testing. Double-blind testing was not possible
because participants would be able to feel the compression
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intervention applied. However, the participants were unable to
identify the compression condition consistently, and were not
informed of the expected effect of the intermittent compression
intervention. Investigators were blinded to the experimental
condition during data collection and analysis.
We did not measure SV and CO directly; continuous estimates
of SV and CO were calculated using the ModelflowTM algorithm
(Wesseling et al., 1993; Jellema et al., 1996; Harms et al., 1999).
While this may be subject to inaccuracies when reported on an
individual basis, aggregate changes in SV and CO determined
by ModelflowTM in response to cardiovascular stressors have
been validated previously (Harms et al., 1999; Pitt et al., 2004;
Manen et al., 2015).
In this study, we tested the efficacy of intermittent calf
compression in a cohort of young healthy controls free of known
cardiovascular disease or impairments. Accordingly, for reasons
mentioned in the discussion, we expect that these results may
underestimate the benefit that 0–60 mmHg ICLF would have in
patient populations who have low orthostatic tolerance, and thus
would be poised to experience greater benefit from the device.
Nonetheless, the baseline (placebo) orthostatic tolerance of our
cohort is lower than population norms. The mean orthostatic
tolerance for males in this study was 29.6 ± 3.0 min, while
for females it was 21.2 ± 2.9 min; while normative values for
orthostatic tolerance are 35± 1.4 min in males, and 29± 1.5 min
females (Protheroe et al., 2013). As intermittent calf compression
was effective in this cohort, we are optimistic that we would see
similar results in patient populations.
We did not objectively measure physical fitness, but are aware
that many of our participants were quite physically fit; increased
muscle bulk and fitness promote angiogenesis which, in turn
increases the pooling potential and reduces orthostatic tolerance
(Harrison, 1986; Pinckard et al., 2019). Perhaps this explains why
their OT was slightly lower than the normative values.
CONCLUSION
Intermittent calf compression from 0 to 60 mmHg (4 s on – 11 s
off) effectively delays the onset of presyncope in young, healthy
adults. The improvement in orthostatic tolerance was associated
with reductions in venous pooling and capillary filtration,
lower heart rates, higher stroke volumes, higher cerebral blood
flow velocity and blunting of orthostatic hypocapnia secondary
to activation of the respiratory muscle pump. Intermittent
calf compression is a promising novel intervention for the
management of disorders of orthostatic intolerance. This
research will be instrumental in the design and production of a
“smart” device that would activate during motionless standing,
and inactivate during ambulation or recumbence to maximize
both physiological gain and patient comfort.
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